Genetics of clinical expression in SLE

被引:33
作者
Namjou, Bahram [1 ]
Kilpatrick, Jeff [1 ]
Harley, John B. [1 ,2 ,3 ]
机构
[1] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA
[3] US Dept Vet Affairs, Med Ctr, Oklahoma City, OK USA
关键词
genetic; systemic lupus erythematosus; autoantibodies; cytokine; expression;
D O I
10.1080/08916930701510962
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic lupus erythematosus (SLE) is the prototype of complex autoimmune diseases and is characterized by extreme breakdown of self-tolerance which results in a wide range of immunologic abnormalities and immune complex formation. Genetic, hormonal and environmental factors are known to contribute to the expression of the disease. SLE is very heterogeneous in clinical manifestations and different autoantibodies may predict different set of clinical outcome, however, despite considerable accumulated knowledge, the detailed pathogenesis of SLE still remains unknown. In genetic studies, recent findings in gene expression analyses strongly support the direct role of cytokines and interferons in various immune dysregulations described in SLE. By recent advances in high-throughput SNP genotyping, the association studies of this complex disease have become more practical and for the first time new genetic association results can be confirmed in different population.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 119 条
[1]   INTERRELATIONSHIPS OF HLA-DR, MB, AND MT PHENOTYPES, AUTOANTIBODY EXPRESSION, AND CLINICAL-FEATURES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
AHEARN, JM ;
PROVOST, TT ;
DORSCH, CA ;
STEVENS, MB ;
BIAS, WB ;
ARNETT, FC .
ARTHRITIS AND RHEUMATISM, 1982, 25 (09) :1031-1040
[2]  
Alcorta D, 2002, EXP NEPHROL, V10, P139
[3]   RELATIONSHIPS OF HLA-DR AND MT ANTIGENS TO AUTOANTIBODY EXPRESSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALVARELLOS, A ;
AHEARN, JM ;
PROVOST, TT ;
DORSCH, CA ;
STEVENS, MB ;
BIAS, WB ;
ARNETT, FC .
ARTHRITIS AND RHEUMATISM, 1983, 26 (12) :1533-1535
[4]   Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells [J].
Atencio, S ;
Amano, H ;
Izui, S ;
Kotzin, BL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (07) :4159-4166
[5]   Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].
Baechler, EC ;
Batliwalla, FM ;
Karypis, G ;
Gaffney, PM ;
Ortmann, WA ;
Espe, KJ ;
Shark, KB ;
Grande, WJ ;
Hughes, KM ;
Kapur, V ;
Gregersen, PK ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615
[6]   Autoimmunity through cytokine-induced dendritic cell activation [J].
Banchereau, J ;
Pascual, V ;
Palucka, AK .
IMMUNITY, 2004, 20 (05) :539-550
[7]  
Barnes BJ, 2003, CANCER RES, V63, P6424
[8]   SEROLOGIC SUBSETS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - AN EXAMINATION OF AUTOANTIBODIES IN RELATIONSHIP TO CLINICAL-FEATURES OF DISEASE AND HLA ANTIGENS [J].
BELL, DA ;
MADDISON, PJ .
ARTHRITIS AND RHEUMATISM, 1980, 23 (11) :1268-1273
[9]   Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies [J].
Bengtsson, AA ;
Sturfelt, G ;
Truedsson, L ;
Blomberg, J ;
Alm, G ;
Vallin, H ;
Rönnblom, L .
LUPUS, 2000, 9 (09) :664-671
[10]   Interferon and granulopoiesis signatures in systemic lupus erythematosus blood [J].
Bennett, L ;
Palucka, AK ;
Arce, E ;
Cantrell, V ;
Borvak, J ;
Banchereau, J ;
Pascual, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :711-723